Friedman BioVentures: Funding, Team & Investors | Startup Intros

Loading organizations...

Friedman BioVentures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 3, 2024	Trio Pharmaceuticals	$3.1M Pre-Series A	Friedman BioVentures	—
Dec 9, 2021	PetDx	$62.0M Series B	Longview Asset Management	Aperture Venture Partners, Declaration Partners, K4 Family Investments, Labcorp, Torch Capital, Valor Equity Partners
Feb 1, 2021	DTx Pharma	$100.0M Series B	Matthew Hammond	Access Biotechnology, Domain Associates, Endeavor Venture Funds, MPM Capital, Oak HC/FT, Polaris Partners, SR One, Versant Ventures, Cormorant Asset Management, Eli Lilly and Company, ExSight Ventures, Janus Henderson Investors, Logos Capital, Surveyor Capital
Dec 1, 2019	DTx Pharma	$3.0M Series A	—	Cantos Ventures, Domain Associates, Endeavor Venture Funds, MPM Capital, Tachyon Ventures, Onne Ganel, Jeffrey Friedman
Jun 1, 2018	MedCrypt	$2.0M Seed	ENIAC Ventures	10100, Addition, Jana Messerschmidt, BoxGroup, Dragonfly Capital Partners, Founder Collective, Founders' Co-op, M.G. Siegler, Javelin Venture Partners, Khosla Ventures, KRM Interests LLC, Lightbank, Lightspeed Venture Partners, Nyca Partners, One Way Ventures, Red Swan Ventures, Renegade Partners, Staircase Ventures, Trinity Ventures, Y Combinator, Ade Olonoh, Balaji Srinivasan, Julian Koh, Louis Beryl, MG Siegler, Nex Cubed, Oronoco Investments, Sway Ventures